The name change is just one announcement from the changing company.
EPAX AS (Aalesund, Norway) has been renamed Epax Norway AS, the company announced last week. The global supplier of omega-3 docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) oils has seen several changes over the last several months, but it insists that its industry commitment will remain the same.
EPAX introduced a new CEO in Terje Bakken this July and now holds a resource center in Hoydebygda, Norway and a recently acquired manufacturing plant in Seals Sands, United Kingdom.
EPAX was acquired by Trygg Pharma, a joint venture of Aker Biomarine (Oslo, Norway) and Lindsay Goldberg (Manhattan, NY) in late 2010.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.